DC Chemicals

All products / DC9969

CCT251921
CAT. NO. DC9969

CCT251921

Pack sizes and prices

Pack sizePrice
100 mg$750 USDRequest a quote / confirm availability →
250 mg$1,300 USDRequest a quote / confirm availability →
1 g$2,600 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

CCT251921 is a potent, selective, and orally bioavailable small-molecule modulators of the mediator complex-associated kinases CDK8 and CDK19. (IC50 data: CDK8:=2.3 nM; CDK19 = 2.6 nM). CCT251921 showed the optimal compromise of in vitro biochemical, pharmacokinetic, and physicochemical properties and is suitable for progression to animal models of cancer. The Mediator complex-associated cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9969
Product nameCCT251921
CAS1607837-31-9
Molecular formulaC21H23ClN6O
Molecular weight410.91
Purity>98%
SMILESCn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — CCT251921 (DC9969)

Related research products

Browse newly added products